Comparison of breast cancer in Indonesia and Malaysia - A clinico-pathological study between dharmais cancer centre Jakarta and university Malaya medical centre, Kuala Lumpur

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 11, 2011, Pages 2943-2946

  Ng, C H ^a   Bhoo Pathy, N ^b   Taib, N A ^a   Teh, Y C ^a   Mun, K S ^a   Amiruddin, A ^c   Sinuraya, Evlina S ^d   Rhodes, A ^e   Yip, C H ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b MINISTRY OF HEALTH   (Malaysia)

^c Royal Taruma Hospital   (Indonesia)

^d Dharmais Cancer Hospital National Cancer Center   (Indonesia)

^e UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

Asia; Breast cancer; Indonesia; Malaysia; Tumor characteristics

Indexed keywords

EID: 84863326539     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aryandono T, Harijadi, Soeripto (2006). Hormone receptor status of operable breast cancers in Indonesia: correlation with other prognostic factors and survival. Asian Pac J Cancer Prev, 7, 321-4.
2. Aryandono T, Harijadi, Soeripto (2006). Survival from operable breast cancer: prognostic factors in Yogyakarta, Indonesia. Asian Pac J Cancer Prev, 7, 455-9.
3. Bloom HJ, Richardson WW (1957). Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer, 11, 359-77.
4. Bueno-de-Mesquita, JM, Nuyten DS, Wesseling J, et al (2010).The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment. Ann Oncol, 21, 40-7.
5. Hammond, ME, D. F. Hayes, Dowsett M, et al (2011). American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28, 2784-95.
6. Harford J, Azavedo E, Fischietto M (2008). Guideline implementation for breast healthcarein low-and middle-income countries: breast healthcare program resource allocation. Cancer, 113, 2282-96.
7. International Agency for Research in Cancer http://globocan.iarc.fr/factsheets/cancers/breast.asp)
8. Lim SE, Back M, Quek E, et al (2007). Clinical observations from a breast cancer registry in Asian women. World J Surg, 31, 1387-92.
9. Mohd Taib, NA, C. H. Yip, Mohd I (2008). Survival analysis of Malaysian women with breast cancer: results from the University of Malaya Medical Centre. Asian Pac J Cancer Prev, 9, 197-202.
10. Norsa'adah B, Rampal KG, Rahman MA, et al (2011). Diagnosis delay of breast cancer and its associated factors in Malaysian women. BMC Cancer, 11, 141.
11. Parsa P, Kandiah M, Abdul Rahman H, et al (2006). Barriers for breast cancer screening among Asian women: a mini literature review. Asian Pac J Cancer Prev, 7, 509-14.
12. Pathy NB, CH Yip, Taib NA et al (2011) Breast cancer in a multi-ethnic Asian setting: results from the Singapore-Malaysia hospital-based breast cancer registry. Breast, 20, S75-80.
13. Porter P (2008). "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med, 358, 213-6.
14. Seow A, SW Duffy, McGee MA, et al (1996). Breast cancer in Singapore: trends in incidence 1968-1992. Int J Epidemiol,25, 40-5.
15. Taib NA, Yip CH, Low W-Y (2011). Recognising symptoms of breast Cancer as a reason for delayed presentation in Asian women - The Psycho-socio-cultural Model for breast symptom appraisal: opportunities for intervention. Asian Pacific J Cancer Prev, 12,1-8.
16. Tan GH, NA Taib, Choo WY, et al (2009). Clinical characteristics of triple-negative breast cancer: experience in an Asian developing country. Asian Pac J Cancer Prev, 10, 395-8.
17. Tan YO, S Han, Lu YS, et al (2010) The prevalence and assessment of ErbB2-positive breast cancer in Asia: a literature survey. Cancer, 116, 5348-57.
18. UNICEF www.unicef.org/infobycountry/
19. Worldbank http://data.worldbank.org/country/indonesia.
20. Yin, WJ, JS Lu, Di GH, et al (2009). Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat, 115, 325-33.
21. Yip CH (2009). Breast cancer in Asia. Methods Mol Biol,471, 51-64.
22. Yip CH, Cazap E, Anderson BO, et al (2010) Breast cancer management in middle-resourcecountries (MRCs): consensus statement from the Breast Health Global Initiative. Breast, 20, S12-9.
23. Yip CH, Pathy NB, Uiterwaal CS, et al (2011). Factors affecting estrogen receptor status in a multiracial Asian country: an analysis of 3557 cases. Breast, 20, S60-4.